Impact of repeated cycles of EGF bispecific angiotoxin (eBAT) administered at a reduced interval from doxorubicin chemotherapy in dogs with splenic haemangiosarcoma. [electronic resource]
Producer: 20210908Description: 664-674 p. digitalISSN:- 1476-5829
- Animals
- Antibiotics, Antineoplastic -- therapeutic use
- Antineoplastic Combined Chemotherapy Protocols -- pharmacology
- Chemotherapy, Adjuvant -- methods
- Dog Diseases -- drug therapy
- Dogs
- Doxorubicin -- therapeutic use
- Epidermal Growth Factor -- pharmacology
- Female
- Hemangiosarcoma -- drug therapy
- Male
- Splenic Neoplasms -- drug therapy
- Treatment Outcome
No physical items for this record
Publication Type: Comparative Study; Journal Article
There are no comments on this title.
Log in to your account to post a comment.